What is TRONOX LIMITED CL A's earnings per share (EPS)?

TRONOX LIMITED CL A (TROX) reported diluted earnings per share of -$2.97 for fiscal year 2025. This represents a -858.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

TRONOX LIMITED CL A (TROX) Financials

TROX

Trailing 12 months to June 30, 2026

Revenue $3.1B +3.7% YoY

Net Income -$549.0M -119.6% YoY

EPS (Diluted) -$3.47 -118.2% YoY

Free Cash Flow -$159.0M +35.4% YoY

Market Cap $627.6M as of Oct 3, 2026

Price / Sales 0.2x on $3.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.5x on $1.2B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TROX SEC filings page.

TRONOX LIMITED CL A (TROX) reported $3.1B in revenue over the twelve months to Jun 30, 2026, up 3.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TROX FY2025 2026-10-03

Tronox's 2025 downturn reached operations, capital spending, and leverage, leaving a more debt-dependent business than two years earlier.

In FY2025, EBITDA was $49M while operating cash flow was $60M, so cash generation roughly tracked weak operating performance rather than the much larger accounting loss. With free cash flow at -$281M, capex of $341M consumed more cash than operations produced, making reinvestment the immediate cash drain.

Gross margin fell to 9.3% in FY2025 and operating margin turned negative at -8.7%, indicating that weaker sales economics—not just lower volume—drove the deterioration. The operating loss of $253M contrasts with positive operating income in FY2024, showing the deterioration reached the core business rather than being confined to below-operating items.

Debt-to-equity rose from 1.6x in FY2024 to 2.2x in FY2025 as equity contracted, so the same asset base is being supported by a larger relative debt burden. Inventory reached $1.65B versus receivables of $289M, making working capital especially tied to stock on hand rather than customer balances.

Financial Health Signals

Financial Health Score 30/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of TRONOX LIMITED CL A's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

TRONOX LIMITED CL A has an operating margin of -8.7%, meaning the company loses $9 on every $100 of revenue. This results in a profitability score of 31/100. This is down from 7.1% the prior year.

Growth

TRONOX LIMITED CL A's revenue declined 5.7% year-over-year, from $3.1B to $2.9B. This contraction results in a growth score of 33/100.

Leverage

TRONOX LIMITED CL A has elevated debt relative to equity (D/E of 2.21), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 1/100, reflecting increased financial risk.

Liquidity

With a current ratio of 2.46, TRONOX LIMITED CL A holds $2.46 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow

While TRONOX LIMITED CL A generated $60.0M in operating cash flow, capex of $341.0M consumed most of it, leaving -$281.0M in free cash flow. This results in a low score of 15/100, reflecting heavy capital investment rather than weak cash generation.

Returns

TRONOX LIMITED CL A posts a -33.1% return on equity (ROE), meaning it loses $33 for every $100 of shareholders' equity. This results in a returns score of 31/100. This is down from -2.7% the prior year.

Altman Z-Score Distress

0.68

TRONOX LIMITED CL A scores 0.68, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

2/9

TRONOX LIMITED CL A passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

TRONOX LIMITED CL A reported a net loss of $470.0M while generating $60.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

TRONOX LIMITED CL A reported an operating loss of $253.0M against $185.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$868.0M

YoY+18.7%

QoQ+14.2%

5Y CAGR-1.3%

10Y CAGR+10.1%

TRONOX LIMITED CL A generated $868.0M in revenue in Q2 2026. This represents an increase of 18.7% from the same quarter a year earlier. Against the prior quarter it is up 14.2%.

EBITDA

$47.0M

YoY+56.7%

QoQ+38.2%

5Y CAGR-26.0%

TRONOX LIMITED CL A's EBITDA was $47.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 56.7% from the same quarter a year earlier. Against the prior quarter it is up 38.2%.

Net Income

-$171.0M

YoY-103.6%

QoQ-66.0%

TRONOX LIMITED CL A reported -$171.0M in net income in Q2 2026. This represents a decrease of 103.6% from the same quarter a year earlier. Against the prior quarter it is down 66.0%.

EPS (Diluted)

-$1.07

YoY-101.9%

QoQ-64.6%

TRONOX LIMITED CL A earned -$1.07 per diluted share (EPS) in Q2 2026. This represents a decrease of 101.9% from the same quarter a year earlier. Against the prior quarter it is down 64.6%.

Cash & Balance Sheet

Free Cash Flow

$60.0M

YoY+209.1%

QoQ+144.4%

5Y CAGR-16.7%

10Y CAGR+2.7%

TRONOX LIMITED CL A generated $60.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 209.1% from the same quarter a year earlier. Against the prior quarter it is up 144.4%.

Cash & Debt

$194.0M

YoY+47.0%

QoQ+54.0%

5Y CAGR-8.5%

10Y CAGR+0.3%

TRONOX LIMITED CL A held $194.0M in cash against $3.1B in long-term debt as of Q2 2026.

Dividends Per Share

$0.05

YoY-60.0%

QoQ0.0%

TRONOX LIMITED CL A paid $0.05 per share in dividends in Q2 2026. This represents a decrease of 60.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

160M

YoY+0.7%

QoQ+0.1%

5Y CAGR+0.8%

TRONOX LIMITED CL A had 160M shares outstanding in Q2 2026. This represents an increase of 0.7% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin

6.3%

YoY-4.5pp

QoQ+0.5pp

5Y change-18.1pp

10Y change-5.1pp

TRONOX LIMITED CL A's gross margin was 6.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Operating Margin

-2.4%

YoY+2.4pp

QoQ+3.0pp

5Y change-18.6pp

TRONOX LIMITED CL A's operating margin was -2.4% in Q2 2026, reflecting core business profitability. This is up 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.0 percentage points.

Net Margin

-19.7%

YoY-8.2pp

QoQ-6.2pp

5Y change-27.6pp

10Y change-4.1pp

TRONOX LIMITED CL A's net profit margin was -19.7% in Q2 2026, showing the share of revenue converted to profit. This is down 8.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.2 percentage points.

Return on Equity

-14.7%

YoY-9.6pp

QoQ-6.7pp

5Y change-18.5pp

10Y change-8.8pp

TRONOX LIMITED CL A's ROE was -14.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.7 percentage points.

Capital Allocation

Capital Expenditures

$45.0M

YoY-45.8%

QoQ-32.8%

5Y CAGR-5.6%

10Y CAGR+7.4%

TRONOX LIMITED CL A invested $45.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 45.8% from the same quarter a year earlier. Against the prior quarter it is down 32.8%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

TROX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TROX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.1B	$2.9B-5.7%	$3.1B+7.9%	$2.9B-17.5%	$3.5B-3.3%	$3.6B+29.5%	$2.8B+4.4%	$2.6B+45.2%	$1.8B+7.1%	$1.7B+29.7%	$1.3B-13.3%	$1.5B-13.1%	$1.7B-9.6%	$1.9B+4.9%	$1.8B+18.7%	$1.5B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.3B+0.9%	$1.3B+11.3%	$1.2B-21.1%	$1.5B-2.5%	$1.5B-11.7%	$1.7B+10.5%	$1.6B+242.0%	-$1.1B
Gross Profit	$190.0M	$269.0M-47.8%	$515.0M+11.5%	$462.0M-44.5%	$832.0M-7.0%	$895.0M+44.1%	$621.0M+33.8%	$464.0M-6.8%	$498.0M+28.0%	$389.0M+192.5%	$133.0M+600.0%	$19.0M-90.8%	$207.0M+8.9%	$190.0M-28.0%	$264.0M-39.9%	$439.0M
R&D Expenses	N/A	$15.0M+7.1%	$14.0M+16.7%	$12.0M0.0%	$12.0M-7.7%	$13.0M+8.3%	$12.0M-29.4%	$17.0M+54.5%	$11.0M+37.5%	$8.0M-11.1%	$9.0M-18.2%	$11.0M0.0%	$11.0M+10.0%	$10.0M+11.1%	$9.0M0.0%	$9.0M
SG&A Expenses	$287.0M	$290.0M-2.0%	$296.0M+7.2%	$276.0M-4.5%	$289.0M-9.1%	$318.0M-8.4%	$347.0M0.0%	$347.0M+30.0%	$267.0M+7.2%	$249.0M+34.6%	$185.0M-7.0%	$199.0M+3.6%	$192.0M+2.7%	$187.0M-21.8%	$239.0M+257.2%	-$152.0M
Operating Income	-$219.0M	-$253.0M-215.5%	$219.0M+17.7%	$186.0M-59.4%	$458.0M-20.6%	$577.0M+112.9%	$271.0M+185.3%	$95.0M-52.5%	$200.0M+41.8%	$141.0M+366.0%	-$53.0M+73.6%	-$201.0M	$0-100.0%	$3.0M-88.0%	$25.0M-91.7%	$302.0M
EBITDA	N/A	$49.0M-90.3%	$504.0M+9.3%	$461.0M-36.6%	$727.0M-16.8%	$874.0M+52.0%	$575.0M+53.3%	$375.0M-5.1%	$395.0M+22.3%	$323.0M+160.5%	$124.0M+138.5%	$52.0M-82.4%	$295.0M-12.2%	$336.0M+42.4%	$236.0M	N/A
Interest Expense	$207.0M	$185.0M+10.1%	$168.0M+6.3%	$158.0M+26.4%	$125.0M-20.4%	$157.0M-16.9%	$189.0M-6.0%	$201.0M+4.1%	$193.0M+2.7%	$188.0M+1.6%	$185.0M+15.6%	$160.0M+29.0%	$124.0M+1.6%	$122.0M+130.2%	$53.0M+76.7%	$30.0M
Income Tax	$112.0M	$15.0M-88.2%	$127.0M-65.0%	$363.0M+289.1%	-$192.0M-370.4%	$71.0M+108.1%	-$881.0M-6392.9%	$14.0M+7.7%	$13.0M+116.7%	$6.0M+104.8%	-$125.0M-643.5%	$23.0M-91.4%	$268.0M+824.1%	$29.0M+123.2%	-$125.0M-725.0%	$20.0M
Net Income	-$549.0M	-$470.0M-879.2%	-$48.0M+84.8%	-$316.0M-163.6%	$497.0M+73.8%	$286.0M-70.5%	$969.0M+989.0%	-$109.0M-1457.1%	-$7.0M+97.5%	-$285.0M-367.2%	-$61.0M+81.5%	-$329.0M+23.0%	-$427.0M-238.9%	-$126.0M-111.1%	$1.1B+368.6%	$242.0M
EPS (Basic)	N/A	-$2.97-858.1%	-$0.31+84.7%	-$2.02-162.9%	$3.21+70.7%	$1.88-72.2%	$6.76+966.7%	-$0.78-1200.0%	-$0.06	N/A	N/A	-$2.75+26.5%	-$3.74-236.9%	-$1.11-109.8%	$11.37	N/A
EPS (Diluted)	-$3.47	-$2.97-858.1%	-$0.31+84.7%	-$2.02-163.9%	$3.16+74.6%	$1.81-72.9%	$6.69+957.7%	-$0.78-1200.0%	-$0.06	N/A	N/A	N/A	-$3.74-236.9%	-$1.11-110.0%	$11.10	N/A
Diluted Shares (Avg)	N/A	158M+0.4%	158M+0.9%	156M-0.5%	157M-0.5%	158M+9.0%	145M+3.6%	140M+13.8%	123M	N/A	N/A	N/A	114M+0.8%	113M+11.8%	101M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$868.0M+18.7%	$760.0M+3.0%	$730.0M+8.0%	$699.0M-13.1%	$731.0M-10.9%	$738.0M-4.7%	$676.0M-1.5%	$804.0M+21.5%
Gross Profit	$55.0M-30.4%	$44.0M-55.6%	$39.0M-66.7%	$52.0M-59.4%	$79.0M-47.3%	$99.0M-17.5%	$117.0M+50.0%	$128.0M+36.2%
SG&A Expenses	$72.0M0.0%	$71.0M-4.1%	$74.0M+7.2%	$70.0M-5.4%	$72.0M-2.7%	$74.0M-6.3%	$69.0M-1.4%	$74.0M+19.4%
Operating Income	-$21.0M+40.0%	-$41.0M+32.8%	-$114.0M-337.5%	-$43.0M-179.6%	-$35.0M-146.1%	-$61.0M-248.8%	$48.0M+500.0%	$54.0M+68.8%
EBITDA	$47.0M+56.7%	$34.0M+240.0%	-$15.0M-111.1%	$24.0M-79.3%	$30.0M-78.6%	$10.0M-91.2%	$135.0M+48.4%	$116.0M+26.1%
Interest Expense	$56.0M+24.4%	$53.0M+26.2%	$50.0M+19.0%	$48.0M+14.3%	$45.0M+7.1%	$42.0M0.0%	$42.0M-6.7%	$42.0M0.0%
Income Tax	$106.0M+2550.0%	$0-100.0%	-$2.0M-104.4%	$8.0M-69.2%	$4.0M-91.1%	$5.0M-54.5%	$45.0M+87.5%	$26.0M+225.0%
Net Income	-$171.0M-103.6%	-$103.0M+7.2%	-$176.0M-486.7%	-$99.0M-296.0%	-$84.0M-625.0%	-$111.0M-1133.3%	-$30.0M+46.4%	-$25.0M-78.6%
EPS (Basic)	-$1.07-101.9%	-$0.65+7.1%	-$1.12-460.0%	-$0.63-293.7%	-$0.53-630.0%	-$0.70-1066.7%	-$0.20+44.4%	-$0.16-77.8%
EPS (Diluted)	-$1.07-101.9%	-$0.65+7.1%	-$1.12-460.0%	-$0.63-293.7%	-$0.53-630.0%	-$0.70-1066.7%	-$0.20+44.4%	-$0.16-77.8%
Diluted Shares (Avg)	160M+0.8%	159M+0.5%	N/A	159M+0.3%	159M-0.5%	158M+0.5%	N/A	158M+0.8%

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses.

TROX Balance Sheet

TROX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$6.2B+3.0%	$6.0B-1.6%	$6.1B-2.7%	$6.3B+5.3%	$6.0B-8.8%	$6.6B+24.7%	$5.3B+13.5%	$4.6B-4.6%	$4.9B-2.0%	$5.0B-1.3%	$5.0B-0.8%	$5.1B-11.1%	$5.7B+3.4%	$5.5B	N/A
Current Assets	$2.3B+5.1%	$2.2B+0.9%	$2.1B+8.9%	$2.0B-4.3%	$2.0B-19.0%	$2.5B+22.0%	$2.1B-18.5%	$2.5B-3.6%	$2.6B-3.6%	$2.7B+110.5%	$1.3B-45.4%	$2.4B-10.3%	$2.7B+22.1%	$2.2B	N/A
Cash & Equivalents	$199.0M+31.8%	$151.0M-44.7%	$273.0M+66.5%	$164.0M-28.1%	$228.0M-63.2%	$619.0M+105.0%	$302.0M-70.8%	$1.0B-7.3%	$1.1B+350.0%	$248.0M+8.3%	$229.0M-82.1%	$1.3B-13.5%	$1.5B+106.9%	$713.0M+363.0%	$154.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.7B+6.5%	$1.6B+9.1%	$1.4B+11.2%	$1.3B+21.9%	$1.0B-7.8%	$1.1B+0.5%	$1.1B+136.1%	$479.0M+1.3%	$473.0M-5.2%	$499.0M-20.8%	$630.0M-18.2%	$770.0M+1.4%	$759.0M-17.0%	$914.0M	N/A
Accounts Receivable	$289.0M+8.6%	$266.0M-8.3%	$290.0M-23.1%	$377.0M-40.3%	$631.0M+16.9%	$540.0M+12.0%	$482.0M+52.1%	$317.0M-3.4%	$328.0M+18.0%	$278.0M-28.9%	$391.0M+41.2%	$277.0M-10.1%	$308.0M-21.2%	$391.0M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.8B+12.3%	$4.2B+2.2%	$4.2B+6.4%	$3.9B-1.1%	$3.9B-16.0%	$4.7B+7.9%	$4.4B+15.1%	$3.8B-1.8%	$3.8B+1.0%	$3.8B-2.7%	$3.9B+19.5%	$3.3B+0.5%	$3.3B+24.1%	$2.6B	N/A
Current Liabilities	$919.0M+5.1%	$874.0M+16.1%	$753.0M-11.4%	$850.0M+3.4%	$822.0M+2.1%	$805.0M+14.7%	$702.0M+134.0%	$300.0M-15.0%	$353.0M-37.4%	$564.0M+2.9%	$548.0M+49.7%	$366.0M+0.8%	$363.0M-22.3%	$467.0M	N/A
Non-Current Liabilities	$3.8B+14.1%	$3.4B-0.8%	$3.4B+11.4%	$3.1B-2.2%	$3.1B-19.8%	$3.9B+6.6%	$3.6B+4.9%	$3.5B-0.5%	$3.5B+7.7%	$3.2B-3.6%	$3.4B+15.7%	$2.9B+0.4%	$2.9B+34.1%	$2.2B	N/A
Long-Term Debt	$3.1B+13.5%	$2.8B-1.0%	$2.8B+13.1%	$2.5B-3.7%	$2.6B-21.6%	$3.3B+9.2%	$3.0B-4.8%	$3.1B+0.4%	$3.1B+8.2%	$2.9B-0.8%	$2.9B+22.5%	$2.4B-0.8%	$2.4B+49.2%	$1.6B	N/A
Total Equity	$1.4B-19.5%	$1.8B-9.0%	$1.9B-17.9%	$2.4B+18.2%	$2.0B+17.4%	$1.7B+127.0%	$748.0M+9.5%	$683.0M-17.6%	$829.0M-17.8%	$1.0B+1.1%	$998.0M-38.0%	$1.6B-28.1%	$2.2B-15.5%	$2.6B+252.3%	$752.0M
Retained Earnings	$30.0M-94.6%	$555.0M-18.9%	$684.0M-36.7%	$1.1B+62.9%	$663.0M+52.8%	$434.0M+188.0%	-$493.0M-38.1%	-$357.0M-9.2%	-$327.0M-1621.1%	-$19.0M-120.4%	$93.0M-82.4%	$529.0M-50.7%	$1.1B-18.3%	$1.3B	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$6.0B-3.8%	$6.1B-0.2%	$6.2B+3.0%	$6.3B+1.8%	$6.2B+1.5%	$6.1B+0.8%	$6.0B-1.6%	$6.2B+2.5%
Current Assets	$2.1B-4.3%	$2.2B-1.2%	$2.3B+5.1%	$2.3B+4.0%	$2.2B+0.5%	$2.2B+1.6%	$2.2B+0.9%	$2.2B+4.1%
Cash & Equivalents	$194.0M+47.0%	$126.0M-8.7%	$199.0M+31.8%	$185.0M+10.8%	$132.0M-34.3%	$138.0M-9.2%	$151.0M-44.7%	$167.0M-32.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.5B-13.5%	$1.6B-1.7%	$1.7B+6.5%	$1.7B+13.9%	$1.7B+18.3%	$1.6B+14.4%	$1.6B+9.1%	$1.5B+4.2%
Accounts Receivable	$363.0M+23.5%	$331.0M+3.8%	$289.0M+8.6%	$301.0M-19.3%	$294.0M-23.0%	$319.0M-15.6%	$266.0M-8.3%	$373.0M+30.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$4.8B+5.6%	$4.7B+8.5%	$4.8B+12.3%	$4.7B+11.0%	$4.5B+8.2%	$4.4B+6.5%	$4.2B+2.2%	$4.2B+6.0%
Current Liabilities	$840.0M-21.3%	$895.0M-6.9%	$919.0M+5.1%	$847.0M+3.7%	$1.1B+43.2%	$961.0M+39.1%	$874.0M+16.1%	$817.0M+27.1%
Non-Current Liabilities	$3.9B+14.0%	$3.8B+12.9%	$3.8B+14.1%	$3.9B+12.7%	$3.4B+0.6%	$3.4B-0.1%	$3.4B-0.8%	$3.4B+2.0%
Long-Term Debt	$3.1B+13.6%	$3.1B+13.5%	$3.1B+13.5%	$3.1B+13.3%	$2.7B-1.2%	$2.8B-1.0%	$2.8B-1.0%	$2.8B-0.8%
Total Equity	$1.2B-29.5%	$1.3B-23.0%	$1.4B-19.5%	$1.6B-18.4%	$1.6B-13.3%	$1.7B-11.1%	$1.8B-9.0%	$1.9B-4.0%
Retained Earnings	-$244.0M-176.0%	-$73.0M-117.2%	$30.0M-94.6%	$213.0M-64.9%	$321.0M-50.7%	$425.0M-35.1%	$555.0M-18.9%	$606.0M-20.3%

Not reported in any period shown, so not listed: Goodwill.

TROX Cash Flow Statement

TROX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$101.0M	$60.0M-80.0%	$300.0M+63.0%	$184.0M-69.2%	$598.0M-19.2%	$740.0M+108.5%	$355.0M-13.8%	$412.0M+142.4%	$170.0M+3.0%	$165.0M+96.4%	$84.0M+25.4%	$67.0M-52.5%	$141.0M-58.2%	$337.0M+185.6%	$118.0M-55.1%	$263.0M
Depreciation & Amortization	N/A	$302.0M+6.0%	$285.0M+3.6%	$275.0M+2.2%	$269.0M-9.4%	$297.0M-2.3%	$304.0M+8.6%	$280.0M+43.6%	$195.0M+7.1%	$182.0M+2.8%	$177.0M-30.0%	$253.0M-14.2%	$295.0M-11.4%	$333.0M+57.8%	$211.0M	N/A
Stock-Based Compensation	N/A	$20.0M-4.8%	$21.0M+425.0%	$4.0M-84.6%	$26.0M+766.7%	$3.0M+175.0%	-$4.0M-112.5%	$32.0M+52.4%	$21.0M-32.3%	$31.0M+29.2%	$24.0M+9.1%	$22.0M+10.0%	$20.0M+11.1%	$18.0M-43.8%	$32.0M	N/A
Capital Expenditures	$260.0M	$341.0M-7.8%	$370.0M+41.8%	$261.0M-39.0%	$428.0M+57.4%	$272.0M+39.5%	$195.0M-1.5%	$198.0M+69.2%	$117.0M+28.6%	$91.0M+5.8%	$86.0M-47.9%	$165.0M-11.8%	$187.0M+13.3%	$165.0M-0.6%	$166.0M+24.8%	$133.0M
Free Cash Flow	-$159.0M	-$281.0M-301.4%	-$70.0M+9.1%	-$77.0M-145.3%	$170.0M-63.7%	$468.0M+192.5%	$160.0M-25.2%	$214.0M+303.8%	$53.0M-28.4%	$74.0M+3800.0%	-$2.0M+98.0%	-$98.0M-113.0%	-$46.0M-126.7%	$172.0M+458.3%	-$48.0M-136.9%	$130.0M
Investing Cash Flow	-$249.0M	-$328.0M+4.4%	-$343.0M-34.5%	-$255.0M+38.6%	-$415.0M-54.3%	-$269.0M-17.5%	-$229.0M	N/A	N/A	N/A	N/A	N/A	-$187.0M-9.4%	-$171.0M-228.8%	-$52.0M+60.6%	-$132.0M
Financing Cash Flow	$222.0M	$321.0M+552.1%	-$71.0M-140.3%	$176.0M+170.4%	-$250.0M+71.5%	-$877.0M-509.8%	$214.0M+133.5%	-$638.0M-1287.0%	-$46.0M-291.7%	$24.0M+130.8%	-$78.0M-113.0%	$602.0M+556.1%	-$132.0M-121.5%	$614.0M+25.3%	$490.0M+1500.0%	-$35.0M
Dividends Paid	$44.0M	$48.0M-40.0%	$80.0M-10.1%	$89.0M+2.3%	$87.0M+33.8%	$65.0M+62.5%	$40.0M+48.1%	$27.0M+17.4%	$23.0M0.0%	$23.0M-50.0%	$46.0M-60.7%	$117.0M+0.9%	$116.0M+0.9%	$115.0M+88.5%	$61.0M	N/A
Share Buybacks	N/A	N/A	$0	$0-100.0%	$50.0M	$0	$0-100.0%	$288.0M	$0	$0	N/A	N/A	$0	$0-100.0%	$326.0M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$105.0M+275.0%	-$68.0M-112.5%	$121.0M+47.6%	-$57.0M-165.5%	$28.0M-82.5%	-$32.0M-10.3%	$82.0M-25.5%	$87.0M+411.8%
Depreciation & Amortization	$68.0M+4.6%	$75.0M+5.6%	$82.0M+15.5%	$67.0M+8.1%	$65.0M+1.6%	$71.0M-1.4%	$71.0M+2.9%	$62.0M+3.3%
Stock-Based Compensation	N/A	$6.0M+20.0%	N/A	N/A	N/A	$5.0M-16.7%	N/A	N/A
Capital Expenditures	$45.0M-45.8%	$67.0M-39.1%	$68.0M-41.9%	$80.0M-20.8%	$83.0M+9.2%	$110.0M+44.7%	$117.0M+98.3%	$101.0M+87.0%
Free Cash Flow	$60.0M+209.1%	-$135.0M+4.9%	$53.0M+251.4%	-$137.0M-878.6%	-$55.0M-165.5%	-$142.0M-35.2%	-$35.0M-168.6%	-$14.0M+62.2%
Investing Cash Flow	-$30.0M+63.0%	-$67.0M+29.5%	-$73.0M+37.6%	-$79.0M+12.2%	-$81.0M-35.0%	-$95.0M-25.0%	-$117.0M-108.9%	-$90.0M-66.7%
Financing Cash Flow	-$10.0M-120.8%	$67.0M-38.0%	-$24.0M-192.3%	$189.0M+655.9%	$48.0M+194.1%	$108.0M+1000.0%	$26.0M+183.9%	-$34.0M-129.6%
Dividends Paid	$8.0M-60.0%	$8.0M	$8.0M-57.9%	$20.0M0.0%	$20.0M-50.0%	$0-100.0%	$19.0M-5.0%	$20.0M+5.3%

Not reported in any period shown, so not listed: Share Buybacks.

TROX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TROX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	9.3%-7.5pp	16.8%+0.5pp	16.2%-7.9pp	24.1%-1.0pp	25.1%+2.5pp	22.5%+5.0pp	17.6%-9.8pp	27.4%+4.5pp	22.9%+12.8pp	10.2%+8.9pp	1.3%-10.7pp	11.9%+2.0pp	9.9%-4.5pp	14.4%-14.0pp	28.4%
Operating Margin	-8.7%-15.8pp	7.1%+0.6pp	6.5%-6.7pp	13.3%-2.9pp	16.2%+6.3pp	9.8%+6.2pp	3.6%-7.4pp	11.0%+2.7pp	8.3%+12.3pp	-4.0%+9.3pp	-13.3%-13.3pp	0.0%-0.2pp	0.2%-1.2pp	1.4%-18.2pp	19.6%
Net Margin	-16.2%-14.7pp	-1.6%+9.5pp	-11.1%-25.5pp	14.4%+6.4pp	8.0%-27.1pp	35.1%+39.3pp	-4.1%-3.8pp	-0.4%+16.4pp	-16.8%-12.1pp	-4.7%+17.1pp	-21.8%+2.8pp	-24.6%-18.0pp	-6.6%-68.5pp	61.9%+46.2pp	15.7%
Return on Equity	-33.1%-30.4pp	-2.7%+13.6pp	-16.3%-37.4pp	21.1%+6.8pp	14.3%-42.7pp	57.1%+71.6pp	-14.6%-13.6pp	-1.0%+33.4pp	-34.4%-28.3pp	-6.0%+26.9pp	-33.0%-6.5pp	-26.5%-20.9pp	-5.6%-48.4pp	42.8%+10.6pp	32.2%
Return on Assets	-7.6%-6.8pp	-0.8%+4.4pp	-5.1%-13.0pp	7.9%+3.1pp	4.8%-10.0pp	14.8%+16.8pp	-2.1%-1.9pp	-0.1%+5.7pp	-5.9%-4.6pp	-1.2%+5.3pp	-6.5%+1.9pp	-8.4%-6.2pp	-2.2%-22.8pp	20.6%	N/A
Current Ratio	2.460.0x	2.47-0.4x	2.84+0.5x	2.31-0.2x	2.49-0.6x	3.14+0.2x	2.95-5.5x	8.48+1.0x	7.48+2.6x	4.85+2.5x	2.37-4.1x	6.51-0.8x	7.31+2.7x	4.65	N/A
Debt-to-Equity	2.21+0.6x	1.57+0.1x	1.44+0.4x	1.05-0.2x	1.28-0.6x	1.92-2.1x	3.99-0.6x	4.60+0.8x	3.77+0.9x	2.86-0.1x	2.92+1.4x	1.48+0.4x	1.07+0.5x	0.61	N/A
Asset Turnover	0.470.0x	0.510.0x	0.46-0.1x	0.550.0x	0.60+0.2x	0.42-0.1x	0.50+0.1x	0.390.0x	0.35+0.1x	0.260.0x	0.300.0x	0.340.0x	0.340.0x	0.33	N/A
FCF Margin	-9.7%-7.4pp	-2.3%+0.4pp	-2.7%-7.6pp	4.9%-8.2pp	13.1%+7.3pp	5.8%-2.3pp	8.1%+5.2pp	2.9%-1.4pp	4.4%+4.5pp	-0.1%+6.3pp	-6.5%-3.8pp	-2.6%-11.6pp	8.9%+11.6pp	-2.6%-11.1pp	8.4%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	6.3%-4.5pp	5.8%-7.6pp	5.3%-12.0pp	7.4%-8.5pp	10.8%-7.5pp	13.4%-2.1pp	17.3%+5.9pp	15.9%+1.7pp
Operating Margin	-2.4%+2.4pp	-5.4%+2.9pp	-15.6%-22.7pp	-6.2%-12.9pp	-4.8%-14.1pp	-8.3%-13.6pp	7.1%+5.9pp	6.7%+1.9pp
Net Margin	-19.7%-8.2pp	-13.6%+1.5pp	-24.1%-19.7pp	-14.2%-11.1pp	-11.5%-13.4pp	-15.0%-13.9pp	-4.4%+3.7pp	-3.1%-1.0pp
Return on Equity	-14.7%-9.6pp	-8.0%-1.4pp	-12.4%-10.7pp	-6.3%-5.0pp	-5.1%-5.9pp	-6.6%-6.2pp	-1.7%+1.2pp	-1.3%-0.6pp
Return on Assets	-2.9%-1.5pp	-1.7%+0.1pp	-2.8%-2.3pp	-1.6%-1.2pp	-1.4%-1.6pp	-1.8%-1.7pp	-0.5%+0.4pp	-0.4%-0.2pp
Current Ratio	2.55+0.5x	2.42+0.1x	2.460.0x	2.720.0x	2.10-0.9x	2.28-0.8x	2.47-0.4x	2.72-0.6x
Debt-to-Equity	2.69+1.0x	2.42+0.8x	2.21+0.6x	2.01+0.6x	1.67+0.2x	1.64+0.2x	1.57+0.1x	1.450.0x
Asset Turnover	0.150.0x	0.130.0x	0.120.0x	0.110.0x	0.120.0x	0.120.0x	0.110.0x	0.130.0x
FCF Margin	6.9%+14.4pp	-17.8%+1.5pp	7.3%+12.4pp	-19.6%-17.9pp	-7.5%-17.8pp	-19.2%-5.7pp	-5.2%-12.6pp	-1.7%+3.9pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
TRONOX LIMITED CL A TROX	FY2025	$2.9B	-$470.0M	-16.2%	$627.6M	30/100
WESTLAKE CHEMICAL PARTNERS LP WLKP	FY2025	$1.2B	$48.7M	4.2%	$749.7M	73/100
ASP Isotopes Inc. ASPI	FY2025	$23.8M	-$159.8M	N/A	$446.1M	51/100
Green Plains, Inc. GPRE	FY2025	$2.1B	-$121.3M	-5.8%	$1.1B	26/100
AdvanSix Inc. ASIX	FY2025	$1.5B	$49.3M	3.2%	$438.0M	21/100

Where TRONOX LIMITED CL A Ranks

Frequently Asked Questions

What is TRONOX LIMITED CL A's annual revenue?

TRONOX LIMITED CL A (TROX) reported $2.9B in total revenue for fiscal year 2025. This represents a -5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is TRONOX LIMITED CL A's revenue growing?

TRONOX LIMITED CL A (TROX) revenue declined by 5.7% year-over-year, from $3.1B to $2.9B in fiscal year 2025.

Is TRONOX LIMITED CL A profitable?

No, TRONOX LIMITED CL A (TROX) reported a net income of -$470.0M in fiscal year 2025, with a net profit margin of -16.2%.

What is TRONOX LIMITED CL A's EBITDA?

TRONOX LIMITED CL A (TROX) had EBITDA of $49.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does TRONOX LIMITED CL A have?

As of fiscal year 2025, TRONOX LIMITED CL A (TROX) had $199.0M in cash and equivalents against $3.1B in long-term debt.

What is TRONOX LIMITED CL A's gross margin?

TRONOX LIMITED CL A (TROX) had a gross margin of 9.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is TRONOX LIMITED CL A's operating margin?

TRONOX LIMITED CL A (TROX) had an operating margin of -8.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is TRONOX LIMITED CL A's net profit margin?

TRONOX LIMITED CL A (TROX) had a net profit margin of -16.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does TRONOX LIMITED CL A pay dividends?

Yes, TRONOX LIMITED CL A (TROX) paid $0.35 per share in dividends during fiscal year 2025.

What is TRONOX LIMITED CL A's return on equity (ROE)?

TRONOX LIMITED CL A (TROX) has a return on equity of -33.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is TRONOX LIMITED CL A's free cash flow?

TRONOX LIMITED CL A (TROX) recorded an outflow of $281.0M in free cash flow during fiscal year 2025. This represents a -301.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is TRONOX LIMITED CL A's operating cash flow?

TRONOX LIMITED CL A (TROX) generated $60.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are TRONOX LIMITED CL A's total assets?

TRONOX LIMITED CL A (TROX) had $6.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are TRONOX LIMITED CL A's capital expenditures?

TRONOX LIMITED CL A (TROX) invested $341.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does TRONOX LIMITED CL A spend on research and development?

TRONOX LIMITED CL A (TROX) invested $15.0M in research and development during fiscal year 2025.

How many shares does TRONOX LIMITED CL A have outstanding?

TRONOX LIMITED CL A (TROX) had 159M shares outstanding as of fiscal year 2025.

What is TRONOX LIMITED CL A's current ratio?

TRONOX LIMITED CL A (TROX) had a current ratio of 2.46 as of fiscal year 2025, which is generally considered healthy.

What is TRONOX LIMITED CL A's debt-to-equity ratio?

TRONOX LIMITED CL A (TROX) had a debt-to-equity ratio of 2.21 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is TRONOX LIMITED CL A's return on assets (ROA)?

TRONOX LIMITED CL A (TROX) had a return on assets of -7.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is TRONOX LIMITED CL A's P/E ratio?

TRONOX LIMITED CL A (TROX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $627.6M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is TRONOX LIMITED CL A's price-to-sales ratio?

TRONOX LIMITED CL A (TROX) trades at 0.2x sales, its market capitalization divided by revenue of $3.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $627.6M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is TRONOX LIMITED CL A's Altman Z-Score?

TRONOX LIMITED CL A (TROX) has an Altman Z-Score of 0.68, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is TRONOX LIMITED CL A's Piotroski F-Score?

TRONOX LIMITED CL A (TROX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are TRONOX LIMITED CL A's earnings high quality?

TRONOX LIMITED CL A (TROX) reported a net loss of $470.0M while generating $60.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can TRONOX LIMITED CL A cover its interest payments?

TRONOX LIMITED CL A (TROX) reported an operating loss of $253.0M against $185.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is TRONOX LIMITED CL A?

TRONOX LIMITED CL A (TROX) scores 30 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.